Related Experiment Video
Updated: Sep 11, 2025

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
Published on: December 28, 2014
Predictive Value of Neutrophil-to-Lymphocyte Ratio for Cerebral Infarction in Obstructive Sleep Apnea: A
Ziwei Hou1, Chen Chen2, Hong Liu2
1Academy of Medical Sciences, Shanxi Medical University, Taiyuan, People's Republic of China.
Purpose:
Obstructive sleep apnea (OSA) is associated with cerebral infarction (CIF) through inflammatory pathways. The neutrophil-to-lymphocyte ratio (NLR) serves as an inflammation biomarker, but its relationship with CIF in OSA patients remains unclear.
Methods:
A total of 188 OSA patients from The Affiliated Cardiovascular Hospital of Shanxi Medical University (January 2022 to December 2023) were included, consisting of 68 patients with CIF (case group) and 120 without CIF (control group). Data on admission, biochemical tests, and clinical characteristics were collected and compared. Multivariate logistic regression and a nomogram model were employed to identify risk factors, evaluated using receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA).
Results:
Elevated log-transformed NLR (LnNLR), CRP, age, and reduced albumin levels were independently associated with increased CIF risk. The developed nomogram demonstrated excellent discriminative performance (AUC = 0.9372), superior to LnNLR alone (AUC = 0.665). At the optimal cutoff, the model achieved a sensitivity of 82.35% and specificity of 92.50%. Calibration plots showed good agreement between predicted and observed outcomes, and DCA confirmed the model's potential clinical utility.
Conclusion:
High NLR can be used as an emerging criterion for evaluating CIF risk in OSA. The nomogram model is capable of estimating CIF risk accurately, providing useful aid to clinical decision-making. The developed nomogram can be implemented in practice as an aid to help healthcare personnel identify high-risk OSA participants who would be offered early intervention in terms of increased monitoring and prophylaxis. External validation in larger, multi-center cohorts is warranted.

